Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Researchers, clinicians discuss recent findings that could bring hope for people with HIV

Since the onset of the AIDS pandemic more than three decades ago, researchers from the lab and physicians in the clinic have been working toward one shared goal: an AIDS-free world. This week, a conference hosted by the journals Cell and The Lancet brought leading researchers and clinicians together to discuss recent findings that could bring hope to the estimated 35 million people world-wide who live with HIV.

7 Nov 2013

Gentiva Health Services third quarter 2013 net revenues decrease 3.3% to $410.5 million

Gentiva Health Services, Inc., the largest provider of home health and hospice services in the United States based on revenue, today reported third quarter 2013 results.

5 Nov 2013

EcoHealth Alliance discovers new SARS-like coronavirus in Chinese horseshoe bats

EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, announced the discovery of a new SARS-like coronavirus (CoV) in Chinese horseshoe bats.

31 Oct 2013

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

A study led by St. Jude Children's Research Hospital scientists highlights a new approach for developing a universal influenza vaccine that could protect against multiple flu strains, including deadly pandemic strains. The research appears today in the advance online edition of the scientific journal Nature Immunology.

22 Oct 2013

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides, Inc. (the "Company") reports that its optimized injectable FluCide® drug candidate was found to be well tolerated in a non-GLP small animal safety/toxicology study. This study is an important step in the drug development pathway for FluCide.

21 Oct 2013

Gentiva Health Services completes acquisition of Harden Healthcare Holdings

Gentiva Health Services, Inc., the largest provider of home health and hospice services in the United States based on revenue, announced the closing of its acquisition of Harden Healthcare Holdings, Inc..

18 Oct 2013

Viewpoints: 'Surrender' by Republicans; 'myth' of income verification; 'this fight didn't end'

The health care reform law will not be defunded or delayed. No taxes will be cut, and the deal calls for no new cuts to federal spending or limits to social welfare programs. The only things Republicans achieved were billions of dollars in damage to the economy, harm to the nation's reputation and a rock-bottom public approval rating (10/16).

18 Oct 2013

Vivaldi Buys Flu Vaccine R&D Assets From Baxter

...

10 Oct 2013

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.

9 Oct 2013

Survey reveals 60% of Americans report of having Silicon Valley Syndrome

LUMO BodyTech, the makers of the LUMOback smart posture and movement feedback system, today announced national survey results revealing a widespread phenomenon LUMO calls 'Silicon Valley Syndrome'.

9 Oct 2013

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

A new way to attack flu viruses is taking shape in laboratories at Rutgers University, where scientists have identified chemical agents that block the virus's ability to replicate itself in cell culture.

4 Oct 2013

Virginia Tech faculty receives NIH New Innovator Award to research on influenza transmission

Influenza strikes five to 15 percent of the population and is estimated to cost the U.S. economy a hefty $90 million per year. If researchers can improve the understanding of how environmental conditions affect the ability of the influenza virus to survive and infect others while it is airborne, they may be able to help improve prediction and control of its spread.

1 Oct 2013

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

The Vanderbilt Vaccine Research Program (VVRP) has received a contract from the National Institutes of Health (NIH) to continue its work as one of the nation's Vaccine and Treatment Evaluation Units (VTEU).

27 Sep 2013

Researchers find reassuring evidence of H1N1 influenza vaccine's safety during pregnancy

Researchers from Boston University's Slone Epidemiology Center and UC San Diego, in collaboration with the American Academy of Allergy Asthma and Immunology, have found 'reassuring' evidence of the H1N1 influenza vaccine's safety during pregnancy.

24 Sep 2013

EcoHealth Alliance to study land use alteration in disease emergence, climate change in Asia

EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, announced the award of a three-year, $2 million award to address land use alteration as a significant driver of both disease emergence and climate change in Asia.

24 Sep 2013

Researchers find evidence of H1N1 influenza vaccine's safety during pregnancy

Researchers from the University of California, San Diego School of Medicine and Boston University, in collaboration with the American Academy of Allergy Asthma and Immunology (AAAAI), have found evidence of the H1N1 influenza vaccine's safety during pregnancy.

24 Sep 2013

Scientists one step closer to developing universal flu vaccine

Scientists have moved closer to developing a universal flu vaccine after using the 2009 pandemic as a natural experiment to study why some people seem to resist severe illness.

23 Sep 2013

Research roundup: 'Cadillac' plan taxes; 'chronic care management' for substance abusers; long-term care services

As health coverage expands to tens of millions of Americans--through Medicaid expansion in states and the new state health insurance exchanges that will soon begin selling individual health coverage--some Americans with employer-sponsored health coverage are seeing their benefits decrease.

21 Sep 2013

Scientists aim at protecting adults from virulent strain of avian influenza virus

Scientists at the University of Maryland School of Medicine's Center for Vaccine Development are part of nationwide vaccine research aimed at protecting adults from a new and virulent strain of avian (bird) influenza (flu) virus.

20 Sep 2013

Scientists are preparing for possible pandemic spread of new bird flu strain

Scientists at Saint Louis University are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China last spring, joining researchers from seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health (NIH) to test vaccines to protect against the illness in adults.

20 Sep 2013

Pandemic News and Research

Further Reading

Researchers, clinicians discuss recent findings that could bring hope for people with HIV

Gentiva Health Services third quarter 2013 net revenues decrease 3.3% to $410.5 million

EcoHealth Alliance discovers new SARS-like coronavirus in Chinese horseshoe bats

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

Gentiva Health Services completes acquisition of Harden Healthcare Holdings

Viewpoints: 'Surrender' by Republicans; 'myth' of income verification; 'this fight didn't end'

Vivaldi Buys Flu Vaccine R&D Assets From Baxter

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

Survey reveals 60% of Americans report of having Silicon Valley Syndrome

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

Virginia Tech faculty receives NIH New Innovator Award to research on influenza transmission

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

Researchers find reassuring evidence of H1N1 influenza vaccine's safety during pregnancy

EcoHealth Alliance to study land use alteration in disease emergence, climate change in Asia

Researchers find evidence of H1N1 influenza vaccine's safety during pregnancy

Scientists one step closer to developing universal flu vaccine

Research roundup: 'Cadillac' plan taxes; 'chronic care management' for substance abusers; long-term care services

Scientists aim at protecting adults from virulent strain of avian influenza virus

Scientists are preparing for possible pandemic spread of new bird flu strain

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News